0,933  0,003  Cardiovascular analeptic
0,923  0,003  UDP-glucuronosyltransferase substrate
0,862  0,004  Analeptic
0,851  0,004  Respiratory analeptic
0,810  0,002  UGT1A4 substrate
0,776  0,003  Platelet adhesion inhibitor
0,755  0,005  Stroke treatment
0,758  0,021  Antiinflammatory
0,717  0,005  Tumour necrosis factor alpha release inhibitor
0,735  0,025  Apoptosis agonist
0,716  0,017  CYP3A4 substrate
0,704  0,005  Vascular (periferal) disease treatment
0,711  0,015  Teratogen
0,693  0,025  Caspase 9 stimulant
0,685  0,016  Embryotoxic
0,674  0,006  Hepatic disorders treatment
0,656  0,011  Sensitization
0,657  0,017  TNF expression inhibitor
0,644  0,005  Apoptosis antagonist
0,638  0,003  Antiviral (Influenza A)
0,644  0,010  Bone diseases treatment
0,640  0,008  AR expression inhibitor
0,637  0,009  Antiosteoporotic
0,653  0,027  Antineoplastic (breast cancer)
0,634  0,009  NOS3 expression inhibitor
0,628  0,010  UGT1A9 substrate
0,632  0,015  Aldehyde oxidase inhibitor
0,607  0,004  Antiviral (Influenza)
0,604  0,001  UGT2B9 substrate
0,606  0,008  UGT1A6 substrate
0,599  0,011  Antioxidant
0,595  0,012  Antipruritic, allergic
0,601  0,019  Cholesterol antagonist
0,583  0,004  UGT2B4 substrate
0,593  0,022  CYP2C9 substrate
0,586  0,017  Antineoplastic (ovarian cancer)
0,570  0,003  Vasopressin 1A antagonist
0,570  0,003  UGT2B15 substrate
0,543  0,003  Vasopressin 1 antagonist
0,551  0,011  Hypoglycemic
0,540  0,002  Oxytocin antagonist
0,547  0,011  Cardiodepressant
0,539  0,011  Skin irritative effect
0,544  0,021  CYP2C19 substrate
0,520  0,002  Vasopressin 1B antagonist
0,555  0,037  Transcription factor NF kappa B inhibitor
0,517  0,003  Lipocortins synthesis antagonist
0,515  0,003  Sodium/bile acid cotransporter inhibitor
0,518  0,009  Sedative
0,523  0,014  Nitric oxide antagonist
0,522  0,016  NOS2 expression inhibitor
0,527  0,023  5 Hydroxytryptamine release stimulant
0,538  0,040  Antidiabetic
0,538  0,040  Cyclophilin D inhibitor
0,500  0,005  Contraceptive
0,500  0,007  Antiseptic
0,501  0,007  Hair growth stimulant
0,495  0,005  Antiacne
0,495  0,005  UGT2B7 substrate
0,497  0,008  Anesthetic general
0,493  0,013  ICAM1 expression inhibitor
0,491  0,018  Antiprotozoal (Leishmania)
0,483  0,011  UGT1A1 substrate
0,477  0,006  Prostate disorders treatment
0,470  0,009  Hepatoprotectant
0,484  0,025  Spasmolytic
0,464  0,008  Prostatic (benign) hyperplasia treatment
0,485  0,031  Vasodilator, peripheral
0,480  0,029  CYP2C19 inhibitor
0,456  0,005  Antipruritic, non-allergic
0,471  0,023  Antineoplastic (glioma)
0,468  0,023  Metabolic disease treatment
0,448  0,003  Antidiuretic hormone antagonist
0,470  0,030  Antihypercholesterolemic
0,448  0,009  Abortion inducer
0,479  0,047  Antibacterial
0,434  0,003  Vasopressin 2 antagonist
0,466  0,038  Prostate cancer treatment
0,447  0,021  Antineoplastic (glioblastoma multiforme)
0,470  0,044  Antiobesity
0,433  0,010  UGT1A3 substrate
0,441  0,020  Antiparasitic
0,438  0,018  Antimitotic
0,427  0,016  Calcium channel activator
0,458  0,050  GST A substrate
0,415  0,009  Phospholipase C inhibitor
0,423  0,018  Antineoplastic (endocrine cancer)
0,429  0,025  Chemopreventive
0,438  0,035  Antifungal
0,414  0,013  Antiparkinsonian, rigidity relieving
0,432  0,045  Ulceration
0,388  0,002  UGT2B10 substrate
0,399  0,014  Antiviral (Herpes)
0,421  0,039  FMO1 substrate
0,413  0,032  Chemoprotective
0,381  0,004  Antispirochetal
0,399  0,025  Hypolipemic
0,408  0,035  CTGF expression inhibitor
0,409  0,037  Radioprotector
0,375  0,004  Aromatase inhibitor
0,369  0,004  Estrogen agonist
0,364  0,005  Contraceptive male
0,397  0,039  Antineoplastic (pancreatic cancer)
0,394  0,037  Antineoplastic (cervical cancer)
0,363  0,011  Alpha-N-acetylglucosaminidase inhibitor
0,358  0,006  Antifungal enhancer
0,410  0,059  Immunosuppressant
0,383  0,032  Proliferative diseases treatment
0,370  0,019  P-glycoprotein inhibitor
0,370  0,020  Growth hormone agonist
0,380  0,033  DNA damaging
0,365  0,019  GST M1-1 substrate
0,395  0,050  Antithrombotic
0,381  0,036  Antidiabetic (type 2)
0,385  0,042  Lipoprotein disorders treatment
0,374  0,033  Renal disease treatment
0,354  0,014  Interferon gamma antagonist
0,372  0,033  Mutagenic
0,382  0,044  Antineoplastic (melanoma)
0,370  0,033  Antineoplastic (lymphoma)
0,367  0,031  Antineoplastic (renal cancer)
0,367  0,036  Carcinogenic
0,369  0,040  Cytotoxic
0,378  0,051  Caspase 3 stimulant
0,374  0,049  Antipsoriatic
0,341  0,016  Anesthetic
0,330  0,007  UGT2B1 substrate
0,373  0,050  CYP2D6 substrate
0,326  0,005  AMP-activated protein kinase stimulant
0,358  0,040  Cytostatic
0,366  0,050  Antimycobacterial
0,319  0,005  Farnesoid X receptor antagonist
0,319  0,005  Choleretic
0,352  0,039  Antihypoxic
0,319  0,009  Cholesterol synthesis inhibitor
0,311  0,003  Adenylate cyclase stimulant
0,318  0,010  Sulfotransferase substrate
0,310  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,308  0,003  Antirickettsial
0,334  0,030  5 Hydroxytryptamine uptake stimulant
0,318  0,014  Neurotrophic factor enhancer
0,313  0,009  Endometrios treatment
0,317  0,014  Diabetic nephropathy treatment
0,374  0,072  Antineoplastic (lung cancer)
0,350  0,051  Antiepileptic
0,349  0,052  Cardioprotectant
0,338  0,043  Cardiotonic
0,332  0,039  Antineoplastic (liver cancer)
0,328  0,036  Interleukin agonist
0,297  0,006  Estrogen antagonist
0,341  0,050  Interleukin 2 agonist
0,326  0,036  Psychostimulant
0,365  0,075  Antileukemic
0,324  0,041  Angiogenesis stimulant
0,319  0,038  DNA synthesis inhibitor
0,303  0,023  Antialcoholic
0,327  0,047  Antipyretic
0,286  0,006  SULT1A1 substrate
0,293  0,014  Antidiarrheal
0,389  0,111  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,282  0,005  Postmenopausal disorders treatment
0,326  0,049  FMO3 substrate
0,283  0,007  Contraceptive female
0,294  0,019  NOS3 expression enhancer
0,278  0,008  Antiinfertility, female
0,269  0,003  Arachidonic acid antagonist
0,265  0,002  RNA-directed RNA polymerase stimulant
0,267  0,004  Pregnane X receptor agonist
0,267  0,005  Microtubule formation inhibitor
0,256  0,002  UGT2B11 substrate
0,315  0,062  CYP1A2 substrate
0,290  0,040  Gastrin inhibitor
0,266  0,017  Adenylate cyclase inhibitor
0,253  0,009  Androgen antagonist
0,317  0,074  Immunostimulant
0,277  0,037  RNA-directed DNA polymerase inhibitor
0,257  0,018  Glutathione S-transferase substrate
0,241  0,003  Anticholelithogenic
0,292  0,054  Free radical scavenger
0,240  0,005  Tocolytic
0,272  0,038  Muscle relaxant
0,308  0,074  Antineoplastic (brain cancer)
0,236  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,237  0,009  Antineoplastic, alkylator
0,236  0,010  Antiviral (CMV)
0,256  0,030  Antiviral (Hepatitis)
0,307  0,081  Vasodilator, coronary
0,279  0,057  Antiglaucomic
0,258  0,036  Antimutagenic
0,242  0,024  Genotoxic
0,287  0,071  Antituberculosic
0,228  0,014  Retinoprotector
0,254  0,041  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,242  0,029  Protein kinase stimulant
0,216  0,004  Estrogen receptor alpha agonist
0,237  0,026  Antiviral (Hepatitis C)
0,244  0,033  Acaricide
0,214  0,004  Uterine relaxant
0,217  0,008  Actinic keratosis treatment
0,212  0,004  Androgen agonist
0,216  0,009  Estrogen receptor beta antagonist
0,211  0,003  Anabolic
0,295  0,089  Antihypertensive
0,236  0,029  Antipruritic
0,237  0,031  Skeletal muscle relaxant
0,212  0,007  Keratolytic
0,210  0,008  Estrogen receptor alpha antagonist
0,215  0,012  Growth stimulant
0,229  0,028  Interleukin 6 antagonist
0,270  0,070  Flavin-containing monooxygenase substrate
0,222  0,022  DNA polymerase I inhibitor
0,213  0,015  Alcohol dehydrogenase substrate
0,206  0,010  Chronic obstructive bronchitis treatment
0,228  0,033  LDLR expression enhancer
0,249  0,056  Antihypotensive
0,273  0,081  Hypoxia-inducible factor 1 alpha inhibitor
0,233  0,041  Eye irritation, high
0,221  0,030  Toxic, respiratory center
0,193  0,002  Farnesoid X receptor agonist
0,191  0,003  Anesthetic inhalation
0,192  0,004  Glycine receptor agonist
0,222  0,038  Cytidine deaminase inhibitor
0,274  0,092  Antineoplastic (colorectal cancer)
0,186  0,004  Glycine receptor antagonist
0,216  0,036  VEGF expression inhibitor
0,185  0,005  Estrogen receptor beta agonist
0,215  0,036  Melanin inhibitor
0,202  0,027  Antihyperlipoproteinemic
0,228  0,052  Pneumotoxic
0,198  0,023  CF transmembrane conductance regulator agonist
0,181  0,007  Ca2+-transporting ATPase inhibitor
0,253  0,081  Transcription factor STAT3 inhibitor
0,262  0,090  Antineoplastic (colon cancer)
0,181  0,011  Transcription factor NF kappa B stimulant
0,199  0,031  SULT1A3 substrate
0,209  0,041  Amylase inhibitor
0,169  0,005  Bile acid receptor antagonist
0,240  0,078  Acute neurologic disorders treatment
0,164  0,002  SULT2A1 substrate
0,167  0,011  SULT1E1 substrate
0,155  0,005  Na+ K+ transporting ATPase inhibitor
0,218  0,069  VCAM1 expression inhibitor
0,177  0,030  Autism spectrum disorders treatment
0,191  0,044  Antineoplastic (squamous cell carcinoma)
0,233  0,086  Antineoplastic (non-small cell lung cancer)
0,241  0,096  Antineurogenic pain
0,172  0,028  Expectorant
0,149  0,006  SULT1A2 substrate
0,145  0,003  Postcoital contraceptive
0,150  0,011  Lanosterol 14 alpha demethylase inhibitor
0,154  0,016  ABCA1 expression enhancer
0,169  0,032  Antismoking
0,161  0,026  Mucolytic
0,138  0,004  CXC chemokine 3 receptor antagonist
0,139  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,168  0,035  Cyclooxygenase 3 inhibitor
0,158  0,024  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,140  0,007  5-Alpha-reductase inhibitor
0,189  0,057  Liver fibrosis treatment
0,167  0,035  Antihemorrhagic
0,232  0,100  Transcription factor STAT inhibitor
0,237  0,106  Antineoplastic (multiple myeloma)
0,164  0,033  Liver cirrhosis treatment
0,158  0,029  Anticataract
0,146  0,017  Paget's disease treatment
0,178  0,051  Antiparkinsonian, tremor relieving
0,159  0,032  Menstruation disorders treatment
0,129  0,003  Adenylate cyclase 1 inhibitor
0,139  0,014  Antiprotozoal activity enhancer
0,132  0,009  Narcotic antagonist
0,130  0,007  Estrogen-related receptor beta agonist
0,139  0,016  Tourette's syndrome treatment
0,166  0,045  Psychosexual dysfunction treatment
0,137  0,016  Ornithine decarboxylase inhibitor
0,176  0,056  Uterine stimulant
0,126  0,006  Aldosterone antagonist
0,154  0,035  Antiviral (Poxvirus)
0,146  0,028  Adenylate kinase inhibitor
0,242  0,123  CYP3A4 inhibitor
0,182  0,065  Succinate dehydrogenase inhibitor
0,146  0,030  UDP-glucose 4-epimerase inhibitor
0,291  0,175  5 Hydroxytryptamine release inhibitor
0,131  0,016  CDC25A inhibitor
0,149  0,034  GABA C receptor agonist
0,188  0,074  Antihelmintic
0,172  0,059  Diuretic
0,149  0,039  Carcinogenic, group 2B
0,117  0,007  Bombesin 3 receptor antagonist
0,135  0,026  GST T1-1 substrate
0,123  0,014  Hyperparathyroidism treatment
0,143  0,034  CC chemokine 6 receptor antagonist
0,130  0,022  Phosphofructokinase-1 inhibitor
0,214  0,106  Antineoplastic (sarcoma)
0,115  0,008  Antimycoplasmal
0,197  0,091  Antiulcerative
0,117  0,011  Cannabinoid CB2 receptor antagonist
0,172  0,067  Antihelmintic (Nematodes)
0,216  0,112  Amyotrophic lateral sclerosis treatment
0,123  0,020  Glutamate release inhibitor
0,106  0,004  Lipocortins synthesis agonist
0,106  0,005  Acetyl-CoA transferase 2 inhibitor
0,125  0,024  Antidote, mercury
0,131  0,031  Prolactin inhibitor
0,106  0,006  Heme oxygenase stimulant
0,132  0,033  Antineoplastic alkaloid
0,108  0,010  Estradiol 17 beta-dehydrogenase inhibitor
0,266  0,169  Analgesic
0,101  0,003  Microtubule stabilization
0,146  0,050  Aldehyde dehydrogenase inhibitor
0,147  0,050  Anesthetic local
0,124  0,029  Acetylcholine nicotinic antagonist
0,124  0,030  Potassium channel activator
0,215  0,122  Radiosensitizer
0,192  0,099  Cyclic AMP phosphodiesterase inhibitor
0,102  0,010  Glutamate (mGluR6) antagonist
0,147  0,055  Cocaine dependence treatment
0,133  0,041  GABA C receptor antagonist
0,093  0,005  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,093  0,004  Pregnane X receptor antagonist
0,102  0,014  Phospholipase D inhibitor
0,116  0,030  NADH dehydrogenase inhibitor
0,137  0,054  Alkylator
0,121  0,038  Antineoplastic antibiotic
0,190  0,108  Nitric-oxide synthase stimulant
0,145  0,064  Neurotrophic factor
0,115  0,035  Triose-phosphate isomerase inhibitor
0,085  0,005  GABA uptake inhibitor
0,099  0,021  Carbamoyl phosphate synthetase inhibitor
0,225  0,147  Antineoplastic (osteosarcoma)
0,129  0,051  Antiviral (Influenza B)
0,097  0,019  Antidote, organophosphates
0,091  0,013  Hypercalcemia treatment
0,148  0,070  Lipid peroxidase inhibitor
0,151  0,074  Raynaud's phenomenon treatment
0,154  0,077  Carcinogenic, group 1
0,127  0,050  TRPA1 agonist
0,081  0,005  Parathyroid hormone antagonist
0,080  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,204  0,129  Tyrosine 3 hydroxylase inhibitor
0,084  0,010  Alpha-mannosidase inhibitor
0,122  0,049  HDL-cholesterol increasing
0,079  0,007  Glucocorticoid antagonist
0,142  0,069  Heat shock protein 70 antagonist
0,082  0,011  Progesterone antagonist
0,075  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,123  0,054  Photosensitizer
0,161  0,092  Phobic disorders treatment
0,131  0,064  Carcinogenic, group 3
0,156  0,091  ATPase inhibitor
0,081  0,016  Botulinum neurotoxin type A inhibitor
0,113  0,048  GST P1-1 substrate
0,085  0,020  Acyl-CoA dehydrogenase inhibitor
0,125  0,061  Antineoplastic antimetabolite
0,069  0,006  Hypogonadism treatment
0,066  0,004  Tubulin agonist
0,072  0,011  Glucose-6-phosphate isomerase inhibitor
0,062  0,002  Hedgehog signaling activator
0,116  0,057  Neutropenia treatment
0,189  0,130  Superoxide dismutase inhibitor
0,059  0,001  Telomerase stimulant
0,063  0,006  5-Alpha-reductase 2 inhibitor
0,167  0,111  Insulin sensitizer
0,082  0,026  Gaucher disease treatment
0,143  0,087  Thrombolytic
0,198  0,143  Antiischemic
0,127  0,072  Vanilloid 1 agonist
0,120  0,065  Antifungal (Pneumocystis)
0,159  0,105  Non-steroidal antiinflammatory agent
0,128  0,074  Skin whitener
0,078  0,025  Alcohol oxidase inhibitor
0,077  0,023  Andropause treatment
0,135  0,081  Antineoplastic (carcinoma)
0,109  0,056  Toll-Like receptor 4 antagonist
0,059  0,006  Cholesterol absorption inhibitor
0,079  0,026  NMDA 2C receptor antagonist
0,074  0,021  Sphingosine kinase inhibitor
0,072  0,020  Sphingosine kinase 2 inhibitor
0,091  0,039  Nicotinic alpha4beta2 receptor antagonist
0,065  0,014  Mannosidase inhibitor
0,088  0,038  Glutamate dehydrogenase inhibitor
0,061  0,011  Guanylate cyclase inhibitor
0,061  0,012  Liver X receptor alpha agonist
0,121  0,072  Coagulant
0,124  0,076  Renal failure treatment
0,092  0,044  Sodium/hydrogen exchanger 5 inhibitor
0,120  0,074  Cholinergic antagonist
0,082  0,037  Vanilloid 4 agonist
0,117  0,073  Acetylcholine antagonist
0,047  0,004  Ileal bile acid transport inhibitor
0,063  0,019  Potassium channel Kv1.3 blocker
0,072  0,029  Argininosuccinate synthase inhibitor
0,133  0,091  Antifungal (Cryptococcus)
0,069  0,027  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,057  0,016  Geranyltranstransferase inhibitor
0,048  0,007  Carboxypeptidase B inhibitor
0,049  0,008  Cholesterol ester transfer protein antagonist
0,176  0,135  Peptidyltransferase inhibitor
0,202  0,162  Immunomodulator
0,174  0,135  Age-related macular degeneration treatment
0,055  0,016  Retinoid X receptor agonist
0,062  0,024  Nicotinic alpha3beta2 receptor antagonist
0,157  0,121  CYP2B6 inhibitor
0,081  0,046  Antibiotic
0,064  0,028  Alpha tubulin antagonist
0,046  0,010  Ceramide glucosyltransferase inhibitor
0,042  0,008  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,039  0,005  GRP78 expression inhibitor
0,050  0,016  Sphingosine kinase 1 inhibitor
0,099  0,066  Bronchodilator
0,218  0,186  GABA C receptor rho-3 antagonist
0,067  0,034  Biliverdin reductase inhibitor
0,041  0,009  Estrone sulfatase inhibitor
0,037  0,005  Vitamin D receptor antagonist
0,056  0,024  HCV NS3/NS4A protease inhibitor
0,055  0,024  Mineralocorticoid receptor antagonist
0,049  0,019  Thymidine kinase inhibitor
0,039  0,010  Glutamate (mGluR3) agonist
0,038  0,008  Purinergic P2Y15 antagonist
0,034  0,005  Vesicular acetylcholine transporter inhibitor
0,076  0,047  Epoxide hydrolase inhibitor
0,095  0,066  Creatine kinase inhibitor
0,046  0,018  Kainate receptor agonist
0,044  0,016  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,084  0,056  Inducible nitric-oxide synthase inhibitor
0,035  0,008  5-Alpha-reductase 1 inhibitor
0,070  0,043  Glutamate (mGluR7) antagonist
0,101  0,074  Antihypermotility
0,133  0,106  Pulmonary hypertension treatment
0,041  0,014  HMG CoA reductase inhibitor
0,100  0,074  Excitatory amino acid transporter EAAC1 inhibitor
0,040  0,013  ATP citrate lysase inhibitor
0,115  0,090  Bone formation stimulant
0,031  0,006  Corticosteroid-like
0,161  0,137  Antiviral (HIV)
0,044  0,019  Arginase inhibitor
0,044  0,020  Cholecystokinin B agonist
0,053  0,028  Antiviral (Herpesvirus 3, Human)
0,029  0,005  Apical sodium codependent bile acid transporter inhibitor
0,124  0,101  Antidote
0,097  0,074  Ferrochelatase inhibitor
0,028  0,005  NMDA receptor phencyclidine site antagonist
0,031  0,009  Vanilloid 2 agonist
0,031  0,010  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,025  0,004  Thromboxane A2 agonist
0,026  0,004  Vitamin D receptor agonist
0,063  0,043  Antiviral (Parainfluenza)
0,028  0,007  Progesterone agonist
0,093  0,072  Protease inhibitor
0,050  0,030  Phosphorylase inhibitor
0,082  0,063  NMDA receptor antagonist
0,172  0,153  Streptokinase A inhibitor
0,026  0,006  Glucocorticoid agonist
0,049  0,031  Cholesterol esterase inhibitor
0,062  0,043  Prostaglandin F2 alpha antagonist
0,019  0,001  Transcortin receptor antagonist
0,081  0,063  Antiviral (Dengue virus)
0,070  0,054  Aminopeptidase I inhibitor
0,020  0,004  Thromboxane agonist
0,041  0,025  Membrane dipeptidase inhibitor
0,053  0,038  Heparanase inhibitor
0,043  0,030  Opioid kappa receptor agonist
0,094  0,081  Antiprotozoal (Toxoplasma)
0,020  0,008  Prostacyclin agonist
0,025  0,013  Prostaglandin F2 alpha agonist
0,051  0,039  Protein 50S ribosomal subunit inhibitor
0,038  0,027  Glutamate (mGluR8) agonist
0,206  0,195  Histamine release inhibitor
0,015  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,077  0,067  Carcinogenic, group 2A
0,061  0,052  Calcium channel P-type blocker
0,034  0,024  Fumarate hydratase inhibitor
0,053  0,044  Beta tubulin antagonist
0,078  0,069  Sleep apnea treatment
0,064  0,055  Premenstrual syndrome treatment
0,092  0,083  Beta glucuronidase inhibitor
0,014  0,006  Carboxypeptidase B2 inhibitor
0,021  0,013  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,036  0,028  Delayed rectifier potassium channel blocker
0,033  0,025  Antihyperaldosteronism
0,028  0,020  1,3-Beta-glucan synthase inhibitor
0,035  0,028  Glutamate (mGluR3) antagonist
0,071  0,064  GABA B receptor agonist
0,022  0,016  Retinoic acid gamma receptor agonist
0,021  0,014  Retinoid X beta receptor antagonist
0,033  0,027  Retinoid X alpha receptor agonist
0,018  0,013  Methylmalonyl-CoA mutase inhibitor
0,037  0,032  Dopamine D5 agonist
0,064  0,059  CXC chemokine receptor antagonist
0,096  0,091  Antitussive
0,022  0,017  Retinoid X gamma receptor agonist
0,029  0,024  Prostaglandin agonist
0,055  0,051  Purinergic P2X1 antagonist
0,096  0,093  Proteasome inhibitor
0,097  0,094  Beta amyloid protein antagonist
0,091  0,088  Cystathionine beta-synthase inhibitor
0,026  0,022  Retinoid X gamma receptor antagonist
0,056  0,053  Transcription factor AP-1 inhibitor
0,091  0,088  Protein-tyrosine phosphatase 1B inhibitor
0,021  0,018  CYP24 inhibitor
0,021  0,019  Retinoic acid receptor agonist
0,011  0,010  Glutamate (mGluR6) agonist
0,021  0,020  Isoleucine-tRNA ligase inhibitor
0,034  0,034  Retinoid X receptor antagonist
0,141  0,141  Antihypertriglyceridemic

